According to Sino Biopharmaceutical's latest financial reports the company has $2.16 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $2.45 B | -1.01% |
2021-12-31 | $2.47 B | -1.62% |
2020-12-31 | $2.51 B | -7.88% |
2019-12-31 | $2.73 B | 116.77% |
2018-12-31 | $1.26 B | -17.13% |
2017-12-31 | $1.52 B | 23.28% |
2016-12-31 | $1.23 B | 70.79% |
2015-12-31 | $0.72 B | 12.02% |
2014-12-31 | $0.64 B | 60.22% |
2013-12-31 | $0.40 B | 16.97% |
2012-12-31 | $0.34 B | 39.04% |
2011-12-31 | $0.24 B | -32.08% |
2010-12-31 | $0.36 B | 50.4% |
2009-12-31 | $0.24 B | 0.07% |
2008-12-31 | $0.24 B | 6.25% |
2007-12-31 | $0.22 B | 5.42% |
2006-12-31 | $0.21 B | -1.13% |
2005-12-31 | $0.21 B | 392.85% |
2004-12-31 | $44.39 M | 19.17% |
2003-12-31 | $37.25 M | 3.58% |
2002-12-31 | $35.96 M | 63.13% |
2001-12-31 | $22.04 M |